Aflac Incorporated (AFL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Aflac Incorporated (AFL) has a cash flow conversion efficiency ratio of 0.044x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($1.25 Billion) by net assets ($28.69 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Aflac Incorporated - Cash Flow Conversion Efficiency Trend (1989–2024)
This chart illustrates how Aflac Incorporated's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read AFL current and long-term liabilities for a breakdown of total debt and financial obligations.
Aflac Incorporated Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Aflac Incorporated ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Realty Income Corporation
NYSE:O
|
0.024x |
|
Lloyds Banking Group plc
F:LLD2
|
N/A |
|
Wesfarmers Ltd
AU:WES
|
0.317x |
|
Cencora Inc.
NYSE:COR
|
-1.100x |
|
MEITUAN UNSP.ADR/2B
F:9MDA
|
N/A |
|
Robinhood Markets Inc
NASDAQ:HOOD
|
-0.102x |
|
DSV Panalpina A/S
CO:DSV
|
0.049x |
|
NXP Semiconductors NV
NASDAQ:NXPI
|
0.085x |
Annual Cash Flow Conversion Efficiency for Aflac Incorporated (1989–2024)
The table below shows the annual cash flow conversion efficiency of Aflac Incorporated from 1989 to 2024. For the full company profile with market capitalisation and key ratios, see AFL company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $26.10 Billion | $2.71 Billion | 0.104x | -28.51% |
| 2023-12-31 | $21.98 Billion | $3.19 Billion | 0.145x | -24.66% |
| 2022-12-31 | $20.14 Billion | $3.88 Billion | 0.193x | +26.80% |
| 2021-12-31 | $33.25 Billion | $5.05 Billion | 0.152x | +300.74% |
| 2020-12-31 | $157.19 Billion | $5.96 Billion | 0.038x | -79.88% |
| 2019-12-31 | $28.96 Billion | $5.46 Billion | 0.188x | -26.51% |
| 2018-12-31 | $23.46 Billion | $6.01 Billion | 0.256x | +1.92% |
| 2017-12-31 | $24.36 Billion | $6.13 Billion | 0.252x | -13.96% |
| 2016-12-31 | $20.48 Billion | $5.99 Billion | 0.292x | -25.02% |
| 2015-12-31 | $17.38 Billion | $6.78 Billion | 0.390x | +9.19% |
| 2014-12-31 | $18.35 Billion | $6.55 Billion | 0.357x | -50.51% |
| 2013-12-31 | $14.62 Billion | $10.55 Billion | 0.721x | -22.91% |
| 2012-12-31 | $15.98 Billion | $14.95 Billion | 0.936x | +11.74% |
| 2011-12-31 | $12.95 Billion | $10.84 Billion | 0.837x | +32.48% |
| 2010-12-31 | $11.06 Billion | $6.99 Billion | 0.632x | -13.64% |
| 2009-12-31 | $8.42 Billion | $6.16 Billion | 0.732x | -2.12% |
| 2008-12-31 | $6.64 Billion | $4.96 Billion | 0.748x | +41.27% |
| 2007-12-31 | $8.79 Billion | $4.66 Billion | 0.529x | +0.42% |
| 2006-12-31 | $8.34 Billion | $4.40 Billion | 0.527x | -5.74% |
| 2005-12-31 | $7.93 Billion | $4.43 Billion | 0.559x | -5.56% |
| 2004-12-31 | $7.58 Billion | $4.49 Billion | 0.592x | +16.12% |
| 2003-12-31 | $6.65 Billion | $3.39 Billion | 0.510x | +7.32% |
| 2002-12-31 | $6.39 Billion | $3.04 Billion | 0.475x | -9.53% |
| 2001-12-31 | $5.42 Billion | $2.85 Billion | 0.525x | -24.03% |
| 2000-12-31 | $4.69 Billion | $3.25 Billion | 0.691x | -4.74% |
| 1999-12-31 | $3.87 Billion | $2.81 Billion | 0.726x | +9.44% |
| 1998-12-31 | $3.77 Billion | $2.50 Billion | 0.663x | -12.45% |
| 1997-12-31 | $3.43 Billion | $2.60 Billion | 0.757x | -40.24% |
| 1996-12-31 | $2.13 Billion | $2.69 Billion | 1.267x | -8.13% |
| 1995-12-31 | $2.13 Billion | $2.94 Billion | 1.380x | +2.00% |
| 1994-12-31 | $1.75 Billion | $2.37 Billion | 1.352x | +0.08% |
| 1993-12-31 | $1.37 Billion | $1.85 Billion | 1.351x | -2.76% |
| 1992-12-31 | $1.08 Billion | $1.50 Billion | 1.390x | +3.42% |
| 1991-12-31 | $923.50 Million | $1.24 Billion | 1.344x | +5.59% |
| 1990-12-31 | $791.00 Million | $1.01 Billion | 1.273x | +3.03% |
| 1989-12-31 | $702.20 Million | $867.30 Million | 1.235x | -- |
About Aflac Incorporated
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. The Aflac U.S. segment provides accident, disab… Read more